Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Research Report
A Comprehensive Pharmacological and Clinical Review of Lumbricus rubellus Extract and its Primary Bioactive Component, Lumbrokinase
Section 1: Historical Context and Biochemical Profile
The journey of Lumbricus rubellus extract from an ancient folk remedy to a subject of modern clinical investigation represents a compelling case study in ethnopharmacology. This section details its historical roots, the scientific discovery of its key bioactive components, its complex biochemical profile, and the physicochemical properties that underpin its therapeutic potential.
1.1. Traditional Use and Modern Discovery
The medicinal use of earthworms is deeply entrenched in the history of traditional Asian medicine, with documented applications spanning centuries in Chinese, Japanese, Korean, and Vietnamese cultures.[1] Referred to as Dilong (or "Earth Dragon") in Traditional Chinese Medicine, preparations derived from earthworms have been historically prescribed for a wide array of conditions, particularly those believed to involve circulatory stasis, inflammation, and disorders of the liver and spleen.[1] This long-standing empirical use for hematological and circulatory ailments provided a crucial foundation, suggesting the presence of potent, biologically active compounds that warranted scientific exploration.[5]
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/07/20 | Not Applicable | Completed | |||
2020/06/11 | Phase 2 | UNKNOWN | |||
2016/11/29 | Phase 2 | Terminated | Dexa Medica Group | ||
2015/02/13 | Phase 3 | Terminated | Dexa Medica Group | ||
2014/05/26 | Phase 2 | Withdrawn | Dexa Medica Group | ||
2014/05/23 | Phase 2 | Terminated | Dexa Medica Group | ||
2014/05/08 | Phase 2 | Terminated | Dexa Medica Group | ||
2013/07/23 | Phase 1 | Completed | |||
2013/05/31 | Phase 4 | Completed | Dexa Medica Group | ||
2013/02/13 | Phase 3 | Completed | Dexa Medica Group |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.
